fda ruling on tirzepatide today Grants a New Indication for Obesity Management Speak up and share your

instead, we offer a high-end environment where metabolic science meets personalized care

A study of retatrutide in participants with obesity and cardiovascular disease began enrolment for Phase III clinical trials in 2023

In addition, the follow-up duration of ELIXA was also relatively short (2.1 years), especially when compared with the follow-up duration of 5.4 years in the REWIND trial [60, 62]

The likely next phase is tighter scrutiny of wording, substantiation quality, and the boundary between companion nutrition for drug users and implied pharmacological action

I used to think about food all the time and snacking was a huge thing for me and it dampens that desire to reach out to food and it allowed me to find other avenues like exercise and meditation.I was replacing times that I didnt need to eat with other activities, he said

The mean calorie intake was 1,748 kcal/day for the overall sample, 1,700 kcal/day for females, and 1,933 kcal/day for males